CMPO Form 4: COO Exercises Options at $5.44, Sells at ~$19.3
Rhea-AI Filing Summary
CompoSecure, Inc. insider Gregoire Maes reported option exercises and open-market sales of Class A common stock on 08/13/2025 and 08/14/2025. Maes exercised a total of 117,125 shares (19,899 on 08/13 and 97,226 on 08/14) at an exercise price of $5.44 per share via vested stock options and immediately sold those same amounts in multiple transactions at weighted average sale prices of $19.26 (08/13 range $19.25–$19.32) and $19.36 (08/14 range $19.25–$19.60). Following these transactions, Maes beneficially owns 779,062 Class A shares, which include vested shares and various restricted stock units and performance-vesting RSUs documented in the filing.
Positive
- Exercised vested options at $5.44, indicating utilization of compensation-linked equity
- Retains substantial ownership of 779,062 Class A shares including multiple RSU tranches and performance-vesting RSUs
Negative
- Sold 117,125 shares in open-market transactions at weighted averages of $19.26 and $19.36, reducing immediately held free-trading shares
- Significant portion of ownership is tied to performance-vesting RSUs, which are contingent on future targets and continued service
Insights
TL;DR: Insider exercised vested options at $5.44 and sold shares at ~$19.3, retaining substantial ownership through RSUs and performance awards.
The reporting shows option exercises followed by immediate sales, a routine liquidity event where the economic gain equals the spread between the $5.44 exercise price and the ~$19.3 sale price. The reporting person still holds 779,062 Class A shares including multiple tranches of restricted stock units and 291,670 performance-vesting RSUs, indicating continued exposure to the issuer's long-term performance despite the sales. No additional derivative grants or new equity compensation terms are disclosed beyond the vested options and outstanding RSUs.
TL;DR: Transactions are disclosed per Section 16: vested options were exercised and sold, while substantial unvested and performance-based awards remain.
The Form 4 documents compliant reporting of exercises and dispositions. The disclosure clarifies vesting schedules for multiple RSU tranches and confirms that the stock options exercised were fully vested and exercisable. The retention of significant RSUs and performance awards suggests alignment of the reporting person with longer-term shareholder outcomes, while the sales realize gains on vested positions. The filing contains standard explanatory language and commitments to provide trade-level price details on request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 97,226 | $0.00 | -- |
| Exercise | Class A Common Stock | 97,226 | $5.44 | $529K |
| Sale | Class A Common Stock | 97,226 | $19.36 | $1.88M |
| Exercise | Stock Option (Right to Buy) | 19,899 | $0.00 | -- |
| Exercise | Class A Common Stock | 19,899 | $5.44 | $108K |
| Sale | Class A Common Stock | 19,899 | $19.26 | $383K |
Footnotes (1)
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $19.32, inclusive. The reporting person undertakes to provide CompoSecure, Inc. (the "Issuer"), any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $19.60, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Includes (A) 179,228 shares of Class A Common Stock owned by the reporting person, (B) 94,877 shares of Class A Common Stock underlying restricted stock units ("RSUs"), which will vest in three equal installments on February 26, 2028, February 26, 2030 and February 26, 2032, (C) 62,500 shares of Class A Common Stock underlying RSUs that will vest on January 1, 2026, (D) 43,658 shares of Class A Common Stock underlying RSUs that will vest on January 1, 2026, (E) 107,129 shares of Class A Common Stock underlying RSUs that will vest ratably on January 1, 2026 and January 1, 2027, and (cont'd in FN 4) (con't from FN 3) (F) 291,670 performance-vesting RSUs, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the respective governing award agreement, subject in each case to the reporting person's continued service as of the applicable vesting date. The RSUs will be settled into Class A Common Stock upon vesting and may be settled net of shares withheld to pay applicable taxes. All of the shares subject to this option are fully vested and exercisable as of the date hereof.
